2000
Group-Specific Antibody Levels Surrounding Invasive Pneumococcal Illness in Children Infected with Human Immunodeficiency Virus
King J, Borkowsky W, Mahidhara N, Madore D, Shapiro E, Rutstein R, Tan T, Farley J, Dankner W, Nachman S, Simoes E, Flynn P, Clemens J, Hamilton R. Group-Specific Antibody Levels Surrounding Invasive Pneumococcal Illness in Children Infected with Human Immunodeficiency Virus. The Journal Of Infectious Diseases 2000, 181: 1817-1821. PMID: 10823792, DOI: 10.1086/315441.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusAntibody levelsSerum samplesPneumococcal illnessImmunodeficiency virusPneumococcal antibody levelsGeometric mean levelsAntibody valuesPneumococcal serotypesIgG antibodiesGroup 4Mean levelsSeroresponsesIllnessChildrenWeeksSerotypesVirusLevelsSerorespondersELISAAntibodies
1998
Effectiveness of pneumococcal vaccine
Butler J, Spika J, Nichol K, Shapiro E, Breinan R. Effectiveness of pneumococcal vaccine. The Lancet 1998, 351: 1961. PMID: 9654289, DOI: 10.1016/s0140-6736(05)78647-5.Peer-Reviewed Original Research
1992
Outcome of children with occult bacteremia caused by Haemophilus influenzae type b
KORONES D, MARSHALL G, SHAPIRO E. Outcome of children with occult bacteremia caused by Haemophilus influenzae type b. The Pediatric Infectious Disease Journal 1992, 11: 516-520. PMID: 1528640, DOI: 10.1097/00006454-199207000-00002.Peer-Reviewed Original ResearchConceptsHaemophilus influenzae type bOutcome of childrenInfluenzae type bOccult bacteremiaHib bacteremiaYale-New Haven HospitalSerious focal infectionsType BClinical courseMedian ageHib infectionsChildren's HospitalSerious infectionsHealthy childrenMedical recordsFocal infectionBacteremiaHospitalInfectionChildrenOutpatientsSuch antimicrobialsOutcomesBetter definitionAntimicrobials